| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Tax liability | -$713K | -5.97K | -11.09% | $119.34 | 47.9K | May 7, 2021 | Direct | F1 |
| transaction | XYL | Common Stock | Options Exercise | $229K | +3.6K | +7.53% | $63.55 | 51.5K | May 7, 2021 | Direct | |
| transaction | XYL | Common Stock | Sale | -$428K | -3.6K | -7% | $118.87 | 47.9K | May 7, 2021 | Direct | F2, F3 |
| transaction | XYL | Common Stock | Sale | -$123K | -1.03K | -2.16% | $118.78 | 46.8K | May 7, 2021 | Direct | F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Stock Options (Right to Buy) | Disposed to Issuer | $0 | -3.6K | -16.5% | $0.00 | 18.2K | May 7, 2021 | Common | 3.6K | $63.55 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan |
| F2 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021. |
| F3 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,583 Shares were executed at a range of prices from $118.05 to $118.67. 2,021 shares were executed at a range of prices from $119.06 to $119.45. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| F4 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 505 Shares were executed at a range of prices from $117.99 to $118.46. 529 shares were executed at a range of prices from $119.11 to $119.33. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| F5 | The May 7, 2020 stock option grant is scheduled to vest in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023 |